Aceragen Email Format

Biotechnology ResearchNorth Carolina, United States11-50 Employees

Aceragen is a biotechnology research company focused on developing therapies for rare and orphan diseases that currently lack approved treatments. Based in Durham, North Carolina, the organization seeks to provide new therapeutic options that can meaningfully improve the lives of patients and their families. The company emphasizes addressing conditions that have been overlooked by traditional drug development, placing patient needs at the center of its efforts.

Aceragen positions itself in the biotechnology sector by pursuing rare-disease research and engaging in activities beyond drug development, including community awareness and regulatory outreach. Its target market comprises patients with unmet medical needs and the families who support them, as well as regulatory bodies involved in advancing new therapies. Operating with a relatively small team, the company aims to bring attention to neglected diseases and pursue novel treatments from its Durham base.

Sign up for free to view info

Company overview Employee directory